ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,967.84
-0.22%
US Tech 100
21,102.40
-0.27%
Dow Jones
42,206.82
0.08%
Brent Oil
76.125
0.00%
Bitcoin
102,200.89
0.00%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Recursion Pharmaceuticals Inc (RXRX) Quote

Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

NASDAQ
5.03
-0.08
(-1.57%)
Closed June 21 4:00PM
15 min delayed - Upgrade to Realtime
5.03
0.00
(0.00%)
After Hours: 7:59PM
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
5.03
Bid
5.01
Ask
5.03
Volume
32,067,311
4.90 Day's Range 5.355
3.79 52 Week Range 12.36
Market Cap
2.045B
Previous Close
5.11
Open
5.23
Last Trade
145
@
5.03
(formt)
Last Trade Time
Financial Volume
$ 163,789,932
VWAP
5.1077
Average Volume (3m)
24,500,886
Shares Outstanding
406,495,148
Dividend Yield
-
PE Ratio
-4.40
Earnings Per Share (EPS)
-1.14
Revenue
58.84M
Net Profit
-463.66M

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery... Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.recursion.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Recursion Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RXRX. The last closing price for Recursion Pharmaceuticals was $5.11. Over the last year, Recursion Pharmaceuticals shares have traded in a share price range of $ 3.79 to $ 12.36.

Recursion Pharmaceuticals currently has 406,495,148 shares outstanding. The market capitalization of Recursion Pharmaceuticals is $2.08 billion. Recursion Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.40.

Ask ADVFN Intelligence (AI)

Recursion Pharmaceuticals (RXRX) Options Flow Summary

RXRX Options Flow

Overall Flow

Bearish

Net Premium

-42k

Calls / Puts

33.33%

Buys / Sells

50.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

RXRX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 18 2025
RXRX (-1.57%)

Form 8-K - Current report
Edgar (US Regulatory)
June 18 2025
RXRX (-1.57%)

Form 8-K - Current report
Edgar (US Regulatory)
June 10 2025
RXRX (-1.57%)

Form 8-K - Current report
Edgar (US Regulatory)
May 09 2025
RXRX (-1.57%)

Form 424B7 - Prospectus [Rule 424(b)(7)]
Edgar (US Regulatory)
May 09 2025
RXRX (-1.57%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0751.513622603434.9555.254.78301975834.97895072CS
41.0125.12437810954.026.073.96308837074.94920953CS
12-0.93-15.60402684565.966.113.79245008864.93897902CS
26-0.99-16.44518272436.0212.363.79232324636.37096231CS
52-4.57-47.60416666679.612.363.79149908606.54140213CS
156-2.78-35.5953905257.8116.7453.7972656697.62152139CS
260-24.97-83.23333333333042.813.7954751308.05751146CS

RXRX - Frequently Asked Questions (FAQ)

What is the current Recursion Pharmaceuticals share price?
The current share price of Recursion Pharmaceuticals is $ 5.03
How many Recursion Pharmaceuticals shares are in issue?
Recursion Pharmaceuticals has 406,495,148 shares in issue
What is the market cap of Recursion Pharmaceuticals?
The market capitalisation of Recursion Pharmaceuticals is USD 2.08B
What is the 1 year trading range for Recursion Pharmaceuticals share price?
Recursion Pharmaceuticals has traded in the range of $ 3.79 to $ 12.36 during the past year
What is the PE ratio of Recursion Pharmaceuticals?
The price to earnings ratio of Recursion Pharmaceuticals is -4.4
What is the cash to sales ratio of Recursion Pharmaceuticals?
The cash to sales ratio of Recursion Pharmaceuticals is 34.69
What is the reporting currency for Recursion Pharmaceuticals?
Recursion Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Recursion Pharmaceuticals?
The latest annual turnover of Recursion Pharmaceuticals is USD 58.84M
What is the latest annual profit for Recursion Pharmaceuticals?
The latest annual profit of Recursion Pharmaceuticals is USD -463.66M
What is the registered address of Recursion Pharmaceuticals?
The registered address for Recursion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Recursion Pharmaceuticals website address?
The website address for Recursion Pharmaceuticals is www.recursion.com
Which industry sector does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXTTNext Technology Holding Inc
$ 3.44
(158.65%)
13.84M
WHLRWheeler Real Estate Investment Trust Inc
$ 7.15
(109.06%)
52.35M
CTORCitius Oncology Inc
$ 2.63
(69.68%)
20.77M
LUCYInnovative Eyewear Inc
$ 3.52
(54.39%)
111.21M
LGCLLucas GC Ltd
$ 1.0407
(53.16%)
11.17M
NWGLNature Wood Group Ltd
$ 1.71
(-69.63%)
3.99M
ICUSeaStar Medical Holding Corporation
$ 0.351
(-64.05%)
21.9M
MBRXMoleculin Biotech Inc
$ 0.259999
(-55.40%)
16.84M
RGCRegencell Bioscience Holdings Ltd
$ 37.50
(-40.81%)
2.22M
CGTLCreative Global Technology Holdings Ltd
$ 1.4399
(-36.57%)
6.71M
HCTIHealthcare Triangle Inc
$ 0.0297
(12.08%)
583.72M
DFLIDragonfly Energy Holdings Corporation
$ 0.245
(12.39%)
334.37M
GNLNGreenlane Holdings Inc
$ 0.009
(-13.04%)
262.88M
NVDANVIDIA Corporation
$ 143.85
(-1.12%)
242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.359
(-0.09%)
193.97M

RXRX Discussion

View Posts
lambchops lambchops 2 weeks ago
RXRX is Upppppity!

LC

RXRX
👍️0
3antar 3antar 2 weeks ago
Nice move today, what's up 
👍️0
morokoy morokoy 1 month ago
So for the upcoming annual meeting, I voted
Withhold,
Against
Against.
👍️0
bwrbad bwrbad 1 month ago
$12M is a typo it is $12B, MC from 12B to now at $500M
AI in drug discovery need to be combined with HLRI, RXRX currently at level zero on that and the CEO have no understanding on his level of understanding and knowledge of drug discovery. he realized that and started fast cashing out for personal gain before SP goes to R/S and pinksheet territory.
👍️0
bwrbad bwrbad 2 months ago
RXRX PIPELINE EMT
👍️0
bwrbad bwrbad 2 months ago
that ceo??????????????????. pulling out of it, after shifting $12M RXRX going back to drawing board period
👍️0
lambchops lambchops 2 months ago
Up or down don't wearing a frontRXRX will shake 'n bake a chocolate cake.
LC
RXRX
👍️0
Monksdream Monksdream 2 months ago
RXRX, 10Q due Monday 5/5
👍️0
3antar 3antar 2 months ago
FDAs announcement, can lead to more business for RXRX. Is that why RXRX is soaring today?
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
RXRX BEAST
👍️0
bwrbad bwrbad 2 months ago
superiority in predictability and validation RXRX-NVDA?
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
RXRX BIO BEAST
👍️0
bwrbad bwrbad 2 months ago
unexpected
👍️0
bwrbad bwrbad 3 months ago
problem is recursion CEO, He allowed RXRX to loose 90% value in last 5 year while he made over $17M extra personal gain on top of large compensation pkg and still selling like no tomorrow - when you see that you question -what is his intention - loot using big-talk fake agenda or build to perfection with genuine passion - day by day his fake character becoming prominent - questioning his credibility.
👍️0
bwrbad bwrbad 3 months ago
Look at Corcept’s 90% rise, RXRX's REC994 CCM ph-3 data nearing the same zone
👍️0
TucsonPhil TucsonPhil 3 months ago
All the hype stocks, with negative earnings, will fall first and hardest. I foresee a near future where value stocks, in companies that actually turn a profit, will become favored again.
👍️0
bwrbad bwrbad 3 months ago
CEO MUST HAVE lost his AI drug discovery passion - likely it was never there and underneath it was always a pretentious fake passion for quick personal gain. IMO very soon NVDA will pullout and go for investing in another company.
👍️0
bwrbad bwrbad 3 months ago
my patience ran out, throwing my towel and taking a~50% loss, insiders selling so fiercely kind of scary - disbelieving Gibson's integrity and passion on building RXRX, he is taking about 900K salary and on top selling over couple of million founder shares at this time when supporting the company matters.
👍️0
bwrbad bwrbad 3 months ago
~90M sh short, rec499 Ph3 data
med AI vs. brain logic vs med genr AI gaps = paralysis =
👍️0
bwrbad bwrbad 3 months ago
any reddit member in CCM 994 trial
👍️0
Monksdream Monksdream 3 months ago
You have a point

👍️0
bwrbad bwrbad 4 months ago
Cross road,
👍️0
bwrbad bwrbad 4 months ago
can RXRX - star get realignment with ,,,, - asking NVDA's AI brain & Cathy's unknown brain
👍️0
3antar 3antar 4 months ago
Noted. You are so kind
👍️0
peza77 peza77 4 months ago
Hopelessly overvalued, overhyped AI stuff.
ZERO approved products
If this drops to $3, it could still be over-valued
👍️0
bwrbad bwrbad 4 months ago
dark green like black
👍️0
bwrbad bwrbad 4 months ago
Big volume -- could be green EOD
👍️0
bwrbad bwrbad 4 months ago
once cross 36 - it is open sky.
everyday dips are the advantage point
buying the $200 -$300 /sh stock of 2025 at $11 -$36
👍️0
bwrbad bwrbad 4 months ago
could move $3 -$5 today
👍️0
bwrbad bwrbad 4 months ago
You have to have skin in the game!

Reflecting back on #JPM2024 last week and this shot has to be a personal highlight. I was comparing company tattoos with NVIDIA founder & CEO Jensen Huang when @RecursionPharma Board Chair @RMartinChavez dropped his full sleeve Turing machine!… pic.twitter.com/yDPuFVmQ7u— Chris Gibson (@RecursionChris) January 16, 2024
👍️0
TucsonPhil TucsonPhil 4 months ago
I'd wager that undisclosed information is at play, but that wouldn't be legal, so couldn't possibly be the case.
👍️0
3antar 3antar 4 months ago
So why do you think it keeps going higher! 
👍️0
bwrbad bwrbad 4 months ago
blindfold buy at 20 - 30 then the jump 100 - 200
👍️0
bwrbad bwrbad 4 months ago
RXRX
👍️0
TucsonPhil TucsonPhil 4 months ago
They announce a mixed shelf (dilution), and the price spikes?
👍️0
bwrbad bwrbad 4 months ago
RXRX just started little little sprinting step before planting the pole and jump over that record high pole vault bar
👍 1
bwrbad bwrbad 4 months ago
invest - - soon --- before out of reach.
👍️0
bwrbad bwrbad 4 months ago
this is a stock will gain 200-300% in a single day-- but today - no - it will go back to +3c or -3c in 1h
👍️0
TucsonPhil TucsonPhil 4 months ago
This level of result, will make this company fly:

https://www.globenewswire.com/news-release/2025/02/05/3021646/0/en/Recursion-Presents-Phase-2-Data-for-REC-994-in-CCM-in-Late-Breaking-Oral-Presentation-at-the-International-Stroke-Conference.html
👍️ 1
bwrbad bwrbad 4 months ago
generative AI in making medical miracle
👍️0
bwrbad bwrbad 4 months ago
REC-994 MRI-based brainstem lesion volume reduction : place a $M maker brick now
👍️0
bwrbad bwrbad 5 months ago
70 institution 30 public--that's how RXRX drug working now
👍️0
bwrbad bwrbad 5 months ago
YouTube influencer position - write or call cGibson@recursion.com
👍️0
TucsonPhil TucsonPhil 5 months ago
Exactly, when we see the lending fees start to rise, then I will buy more. Brokers always make money, even when investors lose.
👍️0
bwrbad bwrbad 5 months ago
they all do etard fidal TDA, but that gives the opportunity to buy low. This RxRx defines the future of MED world in AI stage- just buying little little within affordability. definitively it will grow like MSTF GOOG AAPL NVDA AMZN.., All drug lords pfizer, j&j eli, merck roche AZ BMS are lining up behind, just give few months to a year for first $100
👍️0
TucsonPhil TucsonPhil 5 months ago
Fidelity is loaning shares to shorts.
👍️0
bwrbad bwrbad 5 months ago
next piece of clinical update will take it above 20 and after that it is in different league.
👍️0
bwrbad bwrbad 5 months ago
Sure looks like early days of ISRG ILMN,
👍️0
TucsonPhil TucsonPhil 5 months ago
Nvidia invested $50M in this company. ARK is a holder. This will be huge, once their first find gets FDA approval, and proof of concept is secured.
👍️ 1
bwrbad bwrbad 5 months ago
interesting no posters in this
future $200 - $300 stock, and that future not far - see the quality of clinical data, target diseases, and the time it took to reach there - not standard 20 ys but 3y to ph3 and a large advancing failure resistant AI powered pipeline
👍️0

Your Recent History

NASDAQ
RXRX
Recursion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads